Access cutting-edge advanced colorectal carcinoma treatment through this clinical trial at a research site in Pleasanton. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Pleasanton location
Preparing your pre-screening questions…
Access advanced colorectal carcinoma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced colorectal carcinoma treatment provided free
Check if you qualify for this advanced colorectal carcinoma clinical trial in Pleasanton, CA
No-Cost Study Care
Local to Pleasanton
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The UNCOVER study is a longitudinal observational cohort focused on patients at high risk for cancer cachexia. At Kaiser Permanente Northern California, up to 800 individuals with advanced or unresectable non-small cell lung cancer, pancreatic adenocarcinoma, or colorectal cancer will be enrolled, as these malignancies carry a substantial risk of cancer cachexia, which is characterized by progressive loss of weight, muscle, and adipose tissue, accompanied by functional decline and reduced quality of life. Data collected includes demographic, physiologic, and clinical data, including tumor characteristics and biomarkers of inflammation, hormonal and metabolic status, body composition, physical function, and patient reported outcomes. Investigators will identify patient phenotypes (i.e., subgroups) that may reflect distinct biological or clinical pathways underlying cancer cachexia. By characterizing heterogeneity in cancer cachexia, this study aims to inform the development of improved diagnostic criteria and more targeted therapeutic strategies, ultimately enhancing clinical trial design and supportive care for patients with advanced colorectal, lung, or pancreatic cancer.
Sponsor: Kaiser Permanente
Yes, this clinical trial (NCT07776353) has an active research site in Pleasanton, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for advanced colorectal carcinoma treatment options in Pleasanton, CA, this clinical trial (NCT07776353) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Pleasanton research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced colorectal carcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all advanced colorectal carcinoma clinical trials near you to find additional studies recruiting in your area.
See all colorectal cancer clinical trials recruiting in Pleasanton — not just this study.
Browse Colorectal Cancer Trials in Pleasanton →